/Companies

Tiburio Therapeutics

Cambridge, US · Founded 2018 · Delaware corporation · 4 known investors

Find your way into Tiburio Therapeutics

Sign up to see every warm intro you have to Tiburio Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Tiburio Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

JG
James G. McArthurExecutive
ANAbraham N. Ceesay
Abraham N. CeesayExecutive
CM
Christoph M. AdamsNamed on SEC filing

Board

MK
Mette Kirstine AggerBoard director
DM
David MottBoard director
SA
Sandip AgarwalaBoard director
SN
Sara NayeemBoard director

Investors · 4

Reported raises · per SEC filings

Form D private placements

$5M disclosed across 1 round · 2018

▶$5MraisedJan 2019 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Mette Kirstine AggerDirector
  • David MottDirector
  • Sandip AgarwalaDirector
  • Sara NayeemDirector
  • James G. McArthurExecutive Officer
  • Christoph M. AdamsExecutive Officer, Director
  • Abraham N. CeesayExecutive Officer
Offering amount
$31M
Amount sold
$5M
First sale
Dec 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Tiburio Therapeutics's investors?
Tiburio Therapeutics's investors include Alexandria, Longitude Capital, Lundbeckfonden Ventures, New Enterprise Associates (NEA).
How much funding has Tiburio Therapeutics raised?
Tiburio Therapeutics has disclosed $5M raised across 1 round.
Where is Tiburio Therapeutics headquartered?
Tiburio Therapeutics is headquartered in Cambridge, US.